Patent ID: 6932971

Claim:
A hapten-carrier conjugate comprising: (a) a virus-like particle of an RNA phage, comprising at least one first attachment site, and (b) at least one drug of abuse hapten with at least one second attachment site; wherein said second attachment site is associated through at least one covalent bond to said first attachment site so as to form an ordered and repetitive hapten-carrier conjugate, and wherein said drug of abuse is selected from the group consisting of: (i) codeine; (ii) fentanyl; (iii) heroin; (iv) morphine; (v) amphetamine; (vi) cocaine; (vii) methylenedioxymethamphetamine; (viii) methamphetamine; (ix) methylphenidate; (x) nicotine; (xi) cotinine; (xii) nornicotine; (xiii) PCP; (xiv) LSD; (xv) mescaline; (xvi) psilocybin; (xvii) tetrahydrocannabiflol; (xviii) diazepam; (xix) desipramine; (xx) imipramine; (xxi) nortriptyline; and (xxii) the amitriptyline class of drugs.